Results 51 to 60 of about 33,777 (238)

Ali Salâhi Bey’in “Hocasız Ud Öğrenmek Usulü” İsimli Metodunun İncelenmesi

open access: yesAyalgu Disiplinlerarası Türk Mûsikîsi Araştırmaları Dergisi
Bu araştırmanın amacı, Ali Salâhi Bey’in “Hocasız Ud Öğrenmek Usulü” isimli metodunun çeşitli değişkenler açısından incelenmesidir. Metodun dilinin, Osmanlı Türkçesi olması nedeni ile öncelikle metodun günümüz Türkçesine (Latin alfabesine) çevirisi ...
Oğuzcan Kalıver, Barış Karaelma
doaj   +1 more source

Opioid withdrawal syndrome-associated cognitive impairment: A narrative review. [PDF]

open access: yesAm J Addict
Abstract Background and Objectives Opioid withdrawal syndrome (OWS) comprises a transient constellation of subjective symptoms and objective signs expressed by brain and other organs. Although cognitive impairment is well documented in opioid use and addiction, little is known about cognitive impairment that may specifically accompany OWS.
Khan F, Tunali N, Chambers RA.
europepmc   +2 more sources

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

open access: yesAddiction, EarlyView.
Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper   +7 more
wiley   +1 more source

Wonders of Oud

open access: yes, 2019
About oud or ...
Norul Amalina, Sabri   +3 more
core   +2 more sources

5‐Methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) for alcohol use disorder: An open‐label, phase 2, proof‐of‐concept, clinical trial

open access: yesAddiction, EarlyView.
Abstract Background and Aims Psychedelic drugs may help treat alcohol use disorder (AUD). This study evaluated BPL‐003, a novel intranasal powder formulation of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) benzoate salt, in people with moderate–severe AUD enrolled in a standard of care, 10‐week programme of relapse‐prevention oriented Cognitive ...
John Marsden   +10 more
wiley   +1 more source

Lifetime treatment seeking for OUD IVhet model.

open access: yes, 2021
Lifetime treatment seeking for OUD IVhet model.
Long Le (273168)   +4 more
core   +1 more source

Prescribed alternative stimulants among people who use unregulated stimulants: Examining the association between maximum dose reached and medication discontinuation in the first 3 years of implementation in British Columbia, Canada

open access: yesAddiction, EarlyView.
Abstract Background and aims In 2020, British Columbia (BC), Canada, introduced ‘Prescribed Alternatives’ (PA) as an approach to offering regulated substances to people accessing the unregulated supply. This study aimed to estimate and compare prescribing characteristics of dextroamphetamine and methylphenidate stimulant PAs in BC, to estimate ...
Bin Zhao   +11 more
wiley   +1 more source

Oud-Noors « Miọtvidr »

open access: yesRevue belge de philologie et d'histoire, 1950
Derolez René. Oud-Noors « Miọtvidr ». In: Revue belge de philologie et d'histoire, tome 28, fasc. 3-4, 1950. pp. 1049-1060.
openaire   +3 more sources

Joint associations of recovery capital and polygenic risk with electronic health record observed remission and relapse in substance use disorder: Longitudinal evidence from the All of Us research program

open access: yesAddiction, EarlyView.
Abstract Background and aims Recovery capital and genetic liability may be related to substance use disorder (SUD) remission through psychosocial and biologic pathways, but their joint association with remission course remains poorly understood. This question is clinically important because people entering remission differ in recovery resources and ...
Janaka V. Kosgolla, Douglas C. Smith
wiley   +1 more source

Vaderlandliefde in oud-Israel

open access: yesHTS Teologiese Studies / Theological Studies, 1946
No abstract available.
openaire   +4 more sources

Home - About - Disclaimer - Privacy